We are live on ! Find out more
CP

Camelot Portfolios Portfolio holdings

AUM $143M
1-Year Est. Return 14.82%
This Fund
S&P 500
This Quarter Est. Return
+4.09%
1 Year Est. Return
+14.82%
3 Year Est. Return
+41.29%
5 Year Est. Return
+33.84%
10 Year Est. Return
+115.32%
AUM
$248M
AUM Growth
+$53.3M
Cap. Flow
+$51.3M
Cap. Flow %
20.66%
Top 10 Hldgs %
21.47%
Holding
278
New
61
Increased
142
Reduced
38
Closed
22
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDX icon
51
VanEck Gold Miners ETF
GDX
$27.4B
$1.32M 0.53%
41,340
+2,904
+8% +$92.7K
VRP icon
52
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$1.31M 0.53%
+50,742
New +$1.32M
EVV
53
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$1.3M 0.52%
99,280
-60,491
-38% -$796K
PBJ icon
54
Invesco Food & Beverage ETF
PBJ
$107M
$1.28M 0.51%
+28,327
New +$1.22M
FSD
55
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$1.27M 0.51%
81,412
-8,960
-10% -$141K
MAC icon
56
Macerich
MAC
$6.92B
$1.26M 0.51%
72,919
+8,319
+13% +$156K
VHT icon
57
Vanguard Health Care ETF
VHT
$18.6B
$1.26M 0.51%
+4,717
New +$1.2M
ENB icon
58
Enbridge
ENB
$112B
$1.25M 0.5%
31,968
-593
-2% -$23.8K
XOM icon
59
ExxonMobil
XOM
$634B
$1.22M 0.49%
19,859
+2,630
+15% +$164K
VFH icon
60
Vanguard Financials ETF
VFH
$13.6B
$1.2M 0.48%
+12,462
New +$1.21M
HIG icon
61
Hartford Financial Services
HIG
$39.3B
$1.18M 0.48%
17,086
+8,017
+88% +$566K
RGA icon
62
Reinsurance Group of America
RGA
$16.1B
$1.13M 0.46%
10,361
+2,805
+37% +$312K
CVX icon
63
Chevron
CVX
$366B
$1.13M 0.45%
9,589
+1,349
+16% +$153K
ORAN
64
DELISTED
Orange
ORAN
$1.13M 0.45%
106,671
+25,312
+31% +$274K
LH icon
65
Labcorp
LH
$25.9B
$1.11M 0.45%
4,121
+1,034
+33% +$256K
BIIB icon
66
Biogen
BIIB
$30.7B
$1.11M 0.45%
4,629
+679
+17% +$175K
PRDO icon
67
Perdoceo Education
PRDO
$2.12B
$1.1M 0.44%
93,342
+20,011
+27% +$218K
AMZN icon
68
Amazon
AMZN
$2.96T
$1.09M 0.44%
6,560
-1,320
-17% -$226K
JLL icon
69
Jones Lang LaSalle
JLL
$16.7B
$1.09M 0.44%
4,049
-116
-3% -$29.9K
GSIE icon
70
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
$1.09M 0.44%
30,826
+7,067
+30% +$247K
EMD
71
Western Asset Emerging Markets Debt Fund
EMD
$616M
$1.06M 0.43%
82,993
-7,201
-8% -$95.7K
EPRF icon
72
Innovator S&P Investment Grade Preferred ETF
EPRF
$68.2M
$1.06M 0.43%
44,262
+15,830
+56% +$379K
FEX icon
73
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
$1.04M 0.42%
11,243
-9,520
-46% -$859K
OPI
74
DELISTED
Office Properties Income Trust
OPI
$1.02M 0.41%
41,141
+7,901
+24% +$203K
SCHA icon
75
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$1.02M 0.41%
39,768
+2,316
+6% +$59.9K

Similar funds

Camelot Portfolios's Q4 2021 Portfolio in Review

As of Q4 2021, Camelot Portfolios held 278 positions worth $248M, up 27% from $195M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Camelot Portfolios deployed $51.3M of net new capital in Q4 2021, opening 61 new positions and adding to 142 existing holdings. Its largest new stake was Guggenheim Strategic Opportunities Fund: 180,183 shares worth $3.3M.

By sector, the portfolio is most concentrated in Financials at 6.4% of assets, down from 8% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $1.74M trimmed.

  • Camelot Portfolios's largest Q4 2021 buy was Guggenheim Strategic Opportunities Fund: 180,183 shares worth $3.3M.
  • Camelot Portfolios added most to Vanguard Morningstar Small-Cap ETF in Q4 2021, an estimated $2.25M increase.
  • Camelot Portfolios's biggest Q4 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $1.74M.
  • Camelot Portfolios fully exited Guggenheim Enhanced Equity Income Fund in Q4 2021, selling an estimated $2.23M.
  • Camelot Portfolios's ten largest holdings make up 21% of its $248M portfolio in Q4 2021.
  • Camelot Portfolios opened 61 new positions and closed 22 in Q4 2021.
  • Camelot Portfolios's portfolio value rose 27% quarter-over-quarter to $248M.

Based on Camelot Portfolios's 13F filing for Q4 2021, filed 4 Jan 2022.